Response to "Is the outcome of SARS-CoV-2 infection in solid organ transplant recipients really similar to that of the general population?"

Molnar, Miklos Z; Kovesdy, Csaba P; Gupta, Shruti; Leaf, David E

Molnar, Miklos Z; Kovesdy, Csaba P; Gupta, Shruti; Leaf, David E.

Molnar MZ; James D. Eason Transplant Institute, Methodist University Hospital, Memphis, Tennessee.
Kovesdy CP; Department of Surgery, University of Tennessee Health Science Center, Memphis, Tennessee.
Gupta S; Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee.
Leaf DE; Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee.

Am J Transplant ; 21(4): 1672-1673, 2021 04.

Article in English | MEDLINE | ID: covidwho-949397

Subject(s)

COVID-19; Organ Transplantation; Humans; Organ Transplantation/adverse effects; SARS-CoV-2; Transplant Recipients

Keywords

clinical research/practice; complication: infectious; health services and outcomes research; infection and infectious agents - viral; kidney transplantation/nephrology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Organ Transplantation / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Am J Transplant Journal subject: Transplantation Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google